Top Markets
Coin of the day
PT Indofarma Tbk PT Indofarma Tbk

PT Indofarma Tbk

INAF
Rang in Aktien #29054
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Aktienkurs
$0.00748841
Zuletzt synchronisiert: 2024-07-01
Marktkapitalisierung
$23.21M
Veränderung (1 Tag)
-2.83%
Veränderung (1 Jahr)
0.00%
Land
ID
Handel PT Indofarma Tbk (INAF)

Kategorie

Dividendenrendite-Verlauf für PT Indofarma Tbk (INAF)
Dividendenrendite (TTM) von PT Indofarma Tbk (Aktienkürzel: INAF) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für PT Indofarma Tbk (INAF) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber